Abiopharma

Cogent Biosciences Announces KRAS PosterPresentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell Carcinoma

(99% Neutral) Northwest Biotherapeutics, Inc. (NWBO) Provides Business Update

Law Offices of Howard G. Smith Encourages Baxter International, Inc. (BAX) Shareholders To Inquire About Securities Fraud Class Action

Law Offices of Howard G. Smith Encourages MoonLake Immunotherapeutics (MLTX) Shareholders to Inquire About Securities Fraud Class Action

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

New Form SCHEDULE 13D - MAXCYTE, INC. Filed: 2025-10-24 AccNo: 0001486180-25-000006 Size: 6 KB

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages Axsome Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

144 (Report of proposed sale of securities) SEC Filing

📋 Zanotti Katherine S (Director) plans to sell 12K shares of EXACT SCIENCES CORP (at $65.00 each, total $780K) Filed: Oct 24, 2025 | ID: 006543

New Form SCHEDULE 13D - Astria Therapeutics, Inc. Filed: 2025-10-24 AccNo: 0001104659-25-102037 Size: 70 KB

Novanta - Novanta Hosts ISO event for Humanoid Robot Safety Standards

ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics